R. Basser - Concepedia

Author

R. Basser

Also Known As

G Martinelli, J Ring, R Basser, R L Basser, R. Basser, R. L. Basser, R.L. BASSER, R.L. Basser, R.L. Dr. Basser, Roya Basser

Publications

Citations

H-Index

Concepts

All Affiliations

The Royal Melbourne Hospital Hanson Institute Ludwig Cancer Research The University of Sydney Peter MacCallum Cancer Centre

About

R. Basser is an author at The Royal Melbourne Hospital specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	564
2	Cell Biology	1	1	35
3	Immunology	1	1	63
4	Neurology	1	1	19
5	Obstetrics	1	1	35

R. Basser

Publications

801

Citations

H-Index

Page 1

	Year	Citations
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors Scott N. Holden, Sabine Eckhardt, R. Basser, Annals of Oncology MedicinePharmacologyPathologyMalignant TumorsAnti-cancer Agent	2005	306
Broad inter‐individual variations in circulating progenitor cell numbers induced by granulocyte colony‐stimulating factor therapy Andrew W. Roberts, E DeLuca, D Metcalf, Stem Cells	1995	71
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia Mark Rosenthal, Danny Rischin, Grant A. McArthur, Annals of Oncology ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet	2002	63
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer M. D. Green, Prudence A. Francis, Val Gebski, Annals of Oncology Breast OncologyOncologyMedicineBreast CancerGefitinib Treatment	2009	62
Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans C. Glenn Begley, R. Basser, Rachel Mansfield, Blood	1997	59
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. R. Basser, L. Bik To, C. Glenn Begley, PubMed Breast OncologyHigh-risk Breast CancerMedicineCancer ManagementPharmacology	1995	35
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. R. Basser, L.B. To, C. Glenn Begley, Journal of Clinical Oncology	1998	34
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer R. Basser, R. Abraham, L. Bik To, Annals of Oncology Heart FailureOncologyBreast OncologyCardiovascular DiseaseCardiac Effects	1999	32
Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy. R. Basser, M M Sobol, Gavin E. Duggan, Journal of Clinical Oncology Dexrazoxane/epirubicin Dose RatiosOncologyPharmacologyHigh-dose EpirubicinCombination Treatment	1994	28
Abnormal anal cytology in high-risk human papilloma virus infection in HIV-infected Australians J. Anderson, Jennifer Hoy, Richard J. Hillman, Sexually Transmitted Infections	2007	23

Page 1